Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Biomarin Pharmaceutical Inc (BMRN)  
$88.63 1.44 (1.6%) as of 4:30 Fri 4/19


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 188,370,000
Market Cap: 16.70(B)
Last Volume: 1,778,607 Avg Vol: 1,398,026
52 Week Range: $76.22 - $99
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Other

Member Indexes:
    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  811
Guru Rank Value     : 0.9
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   BioMarin Pharmaceutical is a biotechnology company that develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Co.'s commercial products are Aldurazyme (laronidase) for Mucopolysaccharidosis I; Brineura (cerliponase alfa) for the treatment of late infantile neuronal ceroid lipofuscinosis type 2; Kuvan (sapropterin dihydrochloride) for the treatment of phenylketonuria; Naglazyme (galsulfase) the treatment of Mucopolysaccharidosis VI ; Palynziq (pegvaliase-pqpz) for adult patients with phenylketonuria; and Vimizim (elosulfase alpha) for the treatment of Mucopolysaccharidosis IV Type A.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 3,625
Total Buy Value $0 $0 $0 $314,469
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 1
Total Shares Sold 156,079 229,843 273,203 611,547
Total Sell Value $13,472,349 $20,340,408 $24,241,430 $58,103,504
Total People Sold 5 5 6 7
Total Sell Transactions 13 19 25 55
End Date 2024-02-22 2023-11-21 2023-05-23 2022-05-23

   
Records found: 1303
  Page 32 of 53  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Fuchs Henry J EVP, Chief Medical Officer   •       –      –    2010-11-01 4 OE $11.05 $9,205 D/D 833 33,435     -
   Cooper Jeffrey H SVP, Chief Financial Officer   •       –      –    2010-10-29 4 A $11.64 $3,770 D/D 324 26,810     -
   Aselage Steve EVP, Chief Business Officer   •       –      –    2010-10-29 4 A $11.64 $3,421 D/D 294 37,881     -
   Davis George Eric SVP, General Counsel   •       –      –    2010-10-29 4 A $11.64 $4,317 D/D 371 28,272     -
   Baffi Robert EVP, Technical Operations   •       –      –    2010-10-29 4 A $11.64 $5,504 D/D 473 69,713     -
   Fuchs Henry J EVP, Chief Medical Officer   •       –      –    2010-10-29 4 A $13.23 $21,188 D/D 1,602 32,602     -
   Cooper Jeffrey H SVP, Chief Financial Officer   •       –      –    2010-10-29 4 AS $25.00 $727,865 D/D (28,750) 26,486     -
   Cooper Jeffrey H SVP, Chief Financial Officer   •       –      –    2010-10-29 4 OE $11.74 $337,525 D/D 28,750 55,236     -
   Wood Mark VP, Human Resources   •       –      –    2010-10-29 4 S $26.00 $955,500 D/D (36,750) 14,243     -
   Wood Mark VP, Human Resources   •       –      –    2010-10-29 4 OE $17.33 $642,005 D/D 36,750 50,993     -
   Cooper Jeffrey H SVP, Chief Financial Officer   •       –      –    2010-10-25 4 AS $24.00 $365,016 D/D (15,209) 26,486     -
   Cooper Jeffrey H SVP, Chief Financial Officer   •       –      –    2010-10-25 4 OE $5.15 $91,801 D/D 15,209 41,695     -
   Wood Mark VP, Human Resources   •       –      –    2010-10-22 4 S $23.52 $22,042 D/D (937) 14,243     -
   Wood Mark VP, Human Resources   •       –      –    2010-10-22 4 OE $14.39 $13,483 D/D 937 15,180     -
   Fuchs Henry J EVP, Chief Medical Officer   •       –      –    2010-10-01 4 AS $22.30 $18,578 D/D (833) 31,000     -
   Fuchs Henry J EVP, Chief Medical Officer   •       –      –    2010-10-01 4 OE $11.05 $9,205 D/D 833 31,833     -
   Wood Mark VP, Human Resources   •       –      –    2010-09-22 4 S $22.92 $21,497 D/D (938) 14,243     -
   Wood Mark VP, Human Resources   •       –      –    2010-09-22 4 OE $14.39 $13,498 D/D 938 15,181     -
   Cooper Jeffrey H SVP, Chief Financial Officer   •       –      –    2010-09-13 4 S $22.85 $137,106 D/D (6,000) 26,486     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2010-09-08 4 S $22.22 $22,220 D/D (1,000) 95,067     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2010-09-08 4 OE $6.46 $6,460 D/D 1,000 96,067     -
   Aselage Steve EVP, Chief Business Officer   •       –      –    2010-09-08 4 S $22.00 $770,000 D/D (35,000) 37,587     -
   Aselage Steve EVP, Chief Business Officer   •       –      –    2010-09-08 4 OE $11.74 $410,900 D/D 35,000 72,587     -
   Wood Mark VP, Human Resources   •       –      –    2010-09-07 4 S $21.51 $20,156 D/D (937) 14,243     -
   Wood Mark VP, Human Resources   •       –      –    2010-09-07 4 OE $14.39 $13,483 D/D 937 15,180     -
  1303 Records found
  Previous  30  31  32  33  34  35  36  37  38  39  Next   
  Page 32 of 53
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us